Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
143 Cards in this Set
- Front
- Back
Sumatriptan
|
5-HT 1B/1D agonist
- inhibits trigeminal nerve activation - prevents vasoactive peptide release - induces vasoconstriction - Acute Migraine + Cluster Headache - toxicity: coronary vasospasm & tingling |
|
Haloperidol
|
Dopamine antagonist
- Huntington's |
|
Tetrabenazine
|
inhibit VMAT
- limit dopamine packaging & release - Huntington's |
|
Reserpine
|
inhibit VMAT
- limit dopamine packaging & release - Huntington's |
|
Donepezil
|
inhibits AChE
- Alzheimer's - toxicity: nausea, dizziness, insomnia |
|
Galantamine
|
inhibits AChE
- Alzheimer's - toxicity: nausea, dizziness, insomnia |
|
Rivastigmine
|
inhibits ACheE
- Alzheimer's - toxicity: nausea, dizziness, insomnia |
|
Memantine
|
NMDA receptor antagonist
- Alzheimer's - toxicity: dizziness, nausea & hallucinations |
|
Selegiline
|
MAO-B inhibitor = increases Dopamine
- Parkinson's |
|
actions of L-Dopa in Parkinson's
|
crosses BBB and converted to dopamine by dopa decarboxylase
|
|
action of Carbidopa in Parkinson's
|
peripheral decarboxylase inhibitor
- increases bioavailability of L-dopa in brain |
|
side effect of L-dopa & Carbidopa
|
- Arrhythmias: increased peripheral conversion of catecholamines
- Dyskinesia: following administration - Akinesia: btw doses |
|
what effect does Vit.B6 have on L-dopa?
|
increases peripheral metabolism of L-dopa
|
|
which Parkinson's drug improves tremor and rigidity?
|
Benztropine
- antimuscarinic - little effect on bradykinesia |
|
drug for Essential or Familial Tremors
|
Propranolol
- beta-blocker |
|
Entacapone, Tolcapone
|
COMT inhibitors
- prevent L-dopa degradation - Parkinson's |
|
Amantadine
|
increases Dopamine
- Parkinson's - toxicity: ataxia |
|
Pramipexole
|
Dopamine agonist
- Parkinson's |
|
Ropinirole
|
Dopamine agonist
- Parkinson's |
|
Dantrolene
|
prevents Ca2+ release from SR
- Malignant Hyperthermia - Neuroleptic Malignant Syndrome |
|
Succinylcholine
|
NMJ blocking agent
- ACh receptor agonist - produces sustained depolarization & prevents muscle contraction |
|
Phase 1 of NMJ blockade
|
prolonged depolarization
- no antidote - block potentiated by cholinesterase inhibitors |
|
Phase 2 of NMJ blockade
|
depolarized but blocked
- ACh receptors are available, but desensitized - antidote = cholinesterase inhibitors (Neostigmine) |
|
toxicity of depolarizing NMJ blockers
|
hypercalcemia, hyperkalemia (arrhythmias) & malignant hyperthermia
|
|
local anesthetics - esters
|
Procaine, Cocaine, Tetracaine
|
|
local anesthetics - amides
|
Lidocaine, Mepivacaine, Bupivacaine
|
|
action of local anesthetics
|
- block Na+ channels by binding to specific receptors on inner portion of channel
- preferentially bind to activated Na+ channels |
|
action of tertiary amines in local anesthesia
|
penetrate membrane in unchanged form, then bind to ion channels as charged forms
|
|
function of local anesthetics plus vasoconstrictors like Epinephrine
|
- decrease bleeding
- increase anesthesia - decrease systemic concentration |
|
order of nerve blockade
|
smaller diameter fibers > larger diameter fibers
myelinated fibers > unmyelinated fibers ** size factor predominates |
|
order of loss in local anesthetics
|
pain, temperature, touch, pressure
|
|
Bupivacaine toxicity (local anesthetic)
|
severe cardiovascular toxicity
|
|
Propofol
|
potentiates GABA-a
- sedation in ICU - rapid anesthesia induction - short procedures |
|
Ketamine
|
PCP analog - blocks NMDA receptors
- IV anesthetic - cardiovascular stimulant - toxicity: disorientation, hallucinations & bad dreams, increased cerebral blood flow |
|
most common drug used for endoscopy
|
Midazolam
- severe post-op respiratory depression - decreased BP - amnesia |
|
Thiopental
|
barbiturate
- high potency, high lipid solubility, rapid entry into brain - induction of anesthesia & short surgical procedures - decreased cerebral blood flow |
|
how is effect of Thiopental terminated?
|
rapid redistribution into tissue and fat
|
|
inhaled anesthetics
|
Halothane, Enflurance, Isoflurance, Sevoflurane, Methoxyflurane, NO
|
|
effect of inhaled anesthetics
|
myocardial depression
respiratory depression nausea, emesis increase cerebral blood flow |
|
Halothane toxicity (inhaled anesthetic)
|
hepatotoxicity = hepatic necrosis
|
|
Methoxyflurane toxicity (inhaled anesthetic)
|
nephrotoxicity
|
|
Enflurane toxicity (inhaled anesthetic)
|
proconvulsant
|
|
Malignant Hyperthermia
|
caused by inhaled anesthetics (Halothane) except NO
- life-threatening - inherited susceptibility |
|
drugs with DECREASED solubility
|
rapid induction and recovery times
|
|
drugs with INCREASED solubility
|
increased potency = decreased MAC
|
|
definition of MAC
|
Minimal Alveolar Concentration at which 50% of population is anesthetized
- varies with age |
|
solubility of Halothane
|
increased lipid and blood solubility
- high potency and slow induction |
|
solubility of Nitrous Oxide
|
decreased lipid and blood solubility
- fast induction and low potency |
|
HIGH blood/gas partition coefficient
|
- more soluble in blood
- slower onset of action - slower equilibrium with brain |
|
Zolpidem
|
BZ1 subtype of GABA receptor
- insomnia - toxicity: ataxia, confusion & headache |
|
Zaleplon
|
BZ1 subtype of GABA receptor
- insomnia - toxicity: ataxia, confusion & headache |
|
Eszopiclone
|
BZ1 subtype of GABA receptor
- insomnia - toxicity: ataxia, confusion & headache |
|
Benzodiazepines overdose tx.
|
Flumazenil = GABA competitive antagonist
|
|
drugs for Alcohol Withdrawal
|
Diazepam (first) or Chlordiazepoxide
|
|
Benzodiazepines not metabolized by liver
|
Lorazepam & Diazepam
- good for Liver Disease |
|
side effects of Benzodiazepines
|
- dependence
- additive CNA depression effects with alcohol - less respiratory depression & coma with Barbiturates |
|
drug for Sleepwalking
|
Benzodiazepines
|
|
drug for Night Terrors
|
Benzodiazepines
|
|
mechanism of Benzodiazepines
|
increase FREQUENCY (intensity) of CI- channel opening = facilitate GABA-a
- decrease REM sleep |
|
short acting Benzodiazepines
|
Triazolam, Oxazepam & Midazolam
- higher addictive potential |
|
mechanism of Barbiturates
|
increase DURATION of CI- channel opening = facilitate GABA-a
|
|
side effects of Barbiturates
|
- respiratory & cardiovascular depression
- CNS depression - dependence - induce P450 |
|
Barbiturates overdose tx.
|
supportive - assist respiration and maintain BP
|
|
Phenytoin
|
blocks Na+ channels; inhibits glutamate release
toxicity: - nystagmus, diplopia - ataxia - SLE-like syndrome - gingival hyperplasia - hirsutism - megaloblastic anemia - lymphadenopathy |
|
1st line prophylaxis for Status Epilepticus
|
Phenytoin
|
|
epileptic drug that causes gingival hyperplasia
|
Phenytoin
|
|
epileptic drug that causes fetal hydantoin syndrome
|
Phenytoin
|
|
epileptic drug that causes lymphadenopathy
|
Phenytoin
|
|
epileptic drug that causes hirsutism
|
Phenytoin
|
|
epileptic drug that cause mental dulling & kidney stones
|
Topiramate
- blocks Na+ channels - increased GABA action |
|
Topiramate
|
blocks Na+ channels & increases GABA action
- migraine prevention |
|
Gabapentin
|
GABA analog; inhibits activated Ca2+ channels
- peripheral neuropathy, postherpetic neuralgia, migraine prophylaxis & bipolar disorder |
|
epileptic drug used for migraine prophylaxis
|
Gabapentin
|
|
epileptic drug used for peripheral neuropathy
|
Gabapentin
|
|
Gabapentin toxicity
|
sedation & ataxia
|
|
Lamotrigine
|
blocks Na+ channels
- epilepsy - toxicity: Stevens-Johnson Syndrome |
|
1st line treatment for Absence Epilepsy
|
Valproic Acid
|
|
Valproic acid
|
increases Na+ channel inactivation & increases GABA
- toxicity: fatal hepatotoxicity, spina bifida, GI distress, tremor, weight gain |
|
epileptic drug that causes fatal hepatotoxicity
|
Valproic Acid
|
|
epileptic drug that causes neural tube defects in fetus
|
Valproic Acid
|
|
epileptic drug used for Absence seizures that blocks thalamic T-type Ca2+ channels
|
Ethosuzimide
|
|
Ethosuzimide toxicity
|
GI distress, fatigue, headache & urticaria
Stevens-Johnson Syndrome |
|
1st line drug for Trigeminal Neuralgia (sharp pain around jaw)
|
Carbamazepine
- increases Na+ channel inactivation |
|
epileptic drug that causes agranulocytosis & aplastic anemia
|
Carbamazepine
|
|
Carbamazepine toxicity
|
diplopia, ataxia, liver toxicity, SIADH, Stevens-Johnson Syndrome, aplastic anemia & agranulocytosis
|
|
epileptic drugs that induce P450
|
Phenytoin
Carbamazepine Phenobarbital |
|
1st line treatment for seizures of Eclampsia
|
MgSO4
|
|
epileptic drugs used for seizures of Eclampsia
|
Diazepam or Lorazepam
|
|
1st line treatment for acute status epilepticus
|
Diazepam or Lorazepam
|
|
Tiagabine
|
epileptic drug that inhibits GABA reuptake
|
|
Vigabatrin
|
epileptic drug that irreversible inhibits GABA transaminase = increases GABA
|
|
drug used for chronic pain
|
Tramadol
- weak opioid - inhibits Serotonin & NE reuptake |
|
anti epileptic drug converted to Phenobarbital & PEMA
|
Primidone
|
|
mu-opioid receptor PARTIAL agonist and kappa-opioid agonist
|
Butorphanol
- used for severe pain |
|
partial mu-opioid agonist that can cause withdrawal symptoms
|
Pentazocine
|
|
Opioid overdose tx.
|
Naloxone or Naltrexone (greatest affinity for mu receptors)
|
|
tolerance to Opioid analgesics does not develop to what?
|
miosis and constipation
|
|
drug used for maintenance programs for Opioid addicts
|
Methadone
|
|
Opioid used for cough suppression
|
Dextromethorphan
|
|
Opioids used for diarrhea
|
Loperamide & Diphenoxylate
|
|
Opioid mechanism of action
|
mu= Morphine
delta = Enkephalin kappa = Dynorphin - open K+ channels & close Ca2+ channels |
|
clinical use for Opioids
|
pain, cough suppression, diarrhea, acute pulmonary edema
|
|
Latanoprost (PFG-2alpha)
|
increases outflow of aqueous humor
- treat glaucoma - toxicity: darkens color of iris |
|
Acetazolamide in glaucoma
|
- angle closure glaucoma
- decreases aqueous humor synthesis via inhibition of CA |
|
Beta-blockers for Glaucoma
|
Timolol, Betaxolol, Carteolol
- decrease aqueous humor synthesis = via ciliary epithelium |
|
Brimonidine (alpha-2 agonist)
|
decreases aqueous humor synthesis
- Glaucoma |
|
drug for glaucoma emergencies
|
Pilocarpine
- opens meshwork into canal of Schlemm - indirect cholinomimetic |
|
direct cholinomimetics for glaucoma
|
Pilocarpine & Carbachol
- increase outflow of aqueous humor via ciliary muscle contraction & opening of trabecular meshwork |
|
Trazodone
|
inhibits serotonin reuptake
- atypical depression & insomnia - toxicity: sedation, nausea, priapism & postural hypotension |
|
Maprotiline
|
blocks NE reuptake
- atypical depression - toxicity: sedation & orthostatic hypotension |
|
Mirtazapine
|
alpha-2 antagonist & 5-HT2 and 5-HT3 receptor antagonist
- atypical depression - toxicity: sedation, increased appetite, weight gain & dry mouth |
|
Bupropion
|
increases NE and Dopamine
- atypical depression & smoking cessation - toxicity: tachycardia, insomnia, headache, seizure in bulimics - NO sexual side effects |
|
list of MAO inhibitors
|
Tranylcypromine
Phenelzine Isocarboxazid Selegiline |
|
toxicity of MAO inhibitors
|
Hypertensive crisis (ingestion of tyramine)
CNS stimulation |
|
list of TCAs
|
Amitriptyline
Imipramine Doxepin Amoxapine |
|
drug used for bedwetting
|
Imipramine
|
|
drug used for OCD
|
Clomipramine
|
|
side effects of TCAs
|
Convulsions, Coma, Cardiotoxicity
- sedation, postural hypotension, hyperpyrexia and respiratory depression - confusion & hallucinations in elderly |
|
which TCA should be given to elderly?
|
Nortriptyline
|
|
TCA overdose cardiotoxicity
|
NaHCO3
|
|
Venlafaxine
|
inhibits Serotonin & NE reuptake
- depression, generalized anxiety & panic disorders - toxicity: increased BP |
|
Duloxetine
|
inhibits Serotonin & NE reuptake
- depression, Diabetic Peripheral Neuropathy - toxicity: increased BP |
|
list of SSRIs
|
Fluoxetine
Paraxetine Setraline Citalopram |
|
SSRI toxicity
|
- GI distress
- sexual dysfunction - Serotonin Syndrome = hyperthermia, confusion, myoclonus, CV collapse, flushing, diarrhea & seizures |
|
treatment for Serotonin Syndrome
|
Cyproheptadine
- 5-HT2 receptor antagonist |
|
Buspirone
|
stimulates 5-HT1A receptors
- Generalized Anxiety - NO sedation, addiction or tolerance - takes 1-2 weeks to take effect - does not interact with alcohol |
|
Lithium
|
inhibitor of phosphoinositol
- toxicity: tremor, sedation, edema, heart block, hypothyroidism, polyuria (NDI) |
|
drug that causes Ebstein anomaly
|
Lithium
|
|
Ziprasidone toxicity
|
prolong QT interval
- atypical antipsychotic |
|
Clozapine toxicity
|
agranulocytosis & weight gain
|
|
Risperidone toxicity
|
hyperprolactinemia
- ammenorrhea |
|
list of Atypical Antipsychotics
|
Olanzapine
Clozapine Quetiapine Risperidone Aripiprazole Ziprasidone |
|
Tardive Dyskinesia
|
stereotypic oral-facial movements
- result from long-term antipsychotic use |
|
Neuroleptic Malignant Syndrome
|
fever, encephalopathy, vitals unstable, elevated enzymes, rigidity of muscles
- result of antipsychotic use |
|
treatment for Neuroleptic Malignant Syndrome
|
Dantrolene
- D2 agonist |
|
Chlorpromazine toxicity
|
corneal deposits
- antipsychotic |
|
Thioridazine toxicity
|
retinal deposits
|
|
Extrapyramidal system side effects
|
hours = acute dystonia (muscle spasm, stiffness)
days = akathisia (restlessness) weeks = bradykinesia months = tar dive dyskinesia |
|
list of Antipsychotics
|
Haloperidol + "-azines"
- block D2 receptors = increase cAMP |
|
Antipsychotic toxicity
|
- galactorrhea
- dry mouth, constipation - sedation, hypotension - EPS |
|
ADHD
|
Methylphenidate, Amphetamine
|
|
PTSD
|
SSRIs
|
|
Tourette's Syndrome
|
Haloperidol, Risperidone
|